Willie McKinney Ph.D.
Founder & CEO
A tobacco industry regulatory executive and inhalation toxicologist who’s spent more than two decades conducting research and developing product and regulatory strategies that bring better products to market.Meet Willie
Kim Hesse M.A.
Vice President, Sales and Marketing
A nicotine and cannabis industry executive with more than 15 years of industry experience who’s equally comfortable in the lab or a board room building organizational processes and growing the business.Meet Kim
Karin M. Gilligan
Director Regulatory Operations
Certified Scrum Master (CSM) and a Project Management Professional (PMP) with more than 15 years in the tobacco and consumer products industries.Meet Karin
Experienced administrative professional with more than 15 years experience serving senior executives with a smile. Walker is a consummate customer-service pro and works closely with both teams and clients.Meet Christy
Our team is your competitive advantage. Learn more about the people who should be at your regulatory table.
Scott Appleton Ph.D.
Senior scientific and regulatory affairs practitioner who helps clients assess their toxicological and regulatory strategies. Dr. Appleton also is curious about the health and behavioral affects of tobacco use.Meet Scott
Autumn Bernal Ph.D.
Toxicologist and electronic nicotine delivery system (ENDS) expert helping nicotine and cannabis manufacturers develop, prioritize and asses strategic scientific projects in their regulatory roadmap.Meet Autumn
Doug Burton ASQ CQE, CRE, CQA, CQM, CSSBB
World-renowned e-vapor and ENDS safety and reliability engineer with extensive experience in risk assessment, mitigation, hazards and human factor analysis, manufacturing process assessment and development, and battery manufacturing and testing.Meet Doug
Les Edinboro Ph.D.
Forensic and clinical toxicologist and fractional Chief Science Officer who can provide laboratory process improvements, leadership development, and risk management reviews.Meet Les
Higher education marketer and research relations expert turned writer who leverages her experience in proposal development and grant seeking to tell compelling data stories for regulatory submission.Meet Melissa
Ian Fearon Ph.D.
Clinical R&D expert and scientist who’s spent 16 years in tobacco harm reduction providing end-to-end support developing and implementing pre-clinical and clinical research programs for tobacco regulatory submissions in the EU and US. Ian is also a technical writer and subject matter expert in all tobacco harm reduction areas.Meet Ian
Angela Ho-Chen J.D.
Legal counsel and former Center for Tobacco Products lawyer who leverages her regulatory experience to help manufacturers navigate the gray spaces in their journey to market.Meet Angela
Ranulfo Lemus Ph.D.
Toxicologist with a focus in inhalation, combustion, metals and genetic toxicology. Dr. Lemus is also well versed in regulatory stakeholder engagement through his International Tungsten Association work.Meet Ranulfo
Regional government project manager with experience developing policies, regulations and projects related to cannabis regulation.Meet Inge
Biologist and clinical laboratory specialist – with more than 30 years experience in methodology development, QA/QC and validation – who helps clients navigate state and FDA testing requirements.Meet Helen
Cheryl K. Olson Sc.D.
Harvard Medical School psychiatry professor, renowned qualitative and quantitative behavioral researcher and tobacco industry columnist with deep experience in smoking cessation and prevention.Meet Cheryl
Reynaldo Quintana M.S.
Biomedical engineer and inventor with more than 20 years of technical, product development leadership; mechanical design; research and development; and global product stewardship.Meet Reynaldo
Ryan Seltzer Ph.D.
Public health researcher, with an expertise in research design, data analysis and clinical trial program evaluation, who uses AI and traditional statistics to reveal meaningful patterns.Meet Ryan
Neil Sherwood Ph.D.
Psychopharmacologist studying the relationship between product use and consumer health who translates those findings into scientific and regulatory overviews, and ultimately public health advocacy.Meet Neil
Marissa Smith Ph.D.
Physiologist, pharmacologist and toxicologist with end-to-end experience designing in vitro and in vivo studies, from both the laboratory and client side, giving her a unique perspective.Meet Marissa
FDA regulatory consultant who can lead clients through all phases of development – from strategy to research, systems implementation, quality assurance and operations.Meet Elisabeth
Jessica Zdinak Ph.D.
Behavioral Science Researcher with extensive experience in public health and the tobacco industry whose work produces impactful insights and advances in tobacco harm reduction.Meet Jessica
%quote% %author%; %title%
"*" indicates required fields